Results 51 to 60 of about 343,763 (246)
Perinatal outcomes in normotensive versus hypertensive HELLP syndrome
Abstract Objective To compare maternal and neonatal outcomes between women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome with and without associated hypertension. Methods This was a retrospective cohort study at a tertiary university‐affiliated medical center including all singleton HELLP cases >24 weeks gestation (January ...
Matan Anteby +4 more
wiley +1 more source
Objectives To investigate the potential link between nighttime births, unit busyness, and the incidence of perinatal hypoxia or moderate-to-severe hypoxic-ischemic encephalopathy.Methods Retrospective cohort study with nested case control study of all ...
Stephen Wood +3 more
doaj +1 more source
Compare Serum VCAM‐1, NSE, Procalcitonin in Predict Sepsis Induced Encephalopathy in Septic Patients
Serum VCAM‐1 is associated with septic encephalopathy in the first 7 days of sepsis. NSE and procalcitonin were not associated with septic encephalopathy. ABSTRACT Background Sepsis‐associated encephalopathy (SAE) is a common complication of severe sepsis. Increased concentration of Vascular Cell Adhesion Molecule 1 (VCAM‐1) is associated with SAE in a
Chun‐Fu Lin +2 more
wiley +1 more source
Role of mitochondria in neonatal hypoxic-ischemic encephalopathy [PDF]
Neonatal hypoxic-ischemic encephalopathy, an important cause of death as well as long-term disability in survivors, is caused by oxygen and glucose deprivation, and limited blood flow.
Lu, Cheng, Kong, Weijing
core +1 more source
Role of Matrix Metalloproteinase-9 in Neonatal Hypoxic-Ischemic Encephalopathy [PDF]
BACKGROUND: Neonatal encephalopathy is a heterogeneous syndrome characterised by signs of central nervous system dysfunction in the newborn. Matrix metalloproteinase-9(MMP-9) increases the blood-brain barrier permeability, and their inhibitors can reduce
Salah, Mohab M. +5 more
core +1 more source
Trial of erythropoietin for hypoxic-ischemic encephalopathy in newborns [PDF]
BACKGROUND: Neonatal hypoxic-ischemic encephalopathy is an important cause of death as well as long-term disability in survivors. Erythropoietin has been hypothesized to have neuroprotective effects in infants with hypoxic-ischemic encephalopathy, but ...
Rao, Rakesh +4 more
core +1 more source
Hypoxic ischaemic encephalopathy
Neonatal encephalopathy (NE) is a heterogeneous clinical syndrome manifesting as impaired neurological dysfunction, including impaired consciousness or seizures, difficulty in initiating and maintaining breathing, loss of reflexes, and tonus in newborns ...
Toptan, Handan Hakyemez, Tunç, Gaffari
core +1 more source
Hypothermia for newborns with hypoxic-ischemic encephalopathy [PDF]
Therapeutic hypothermia is a standard of care for infants ≥36 weeks gestational age (GA) with moderate-to-severe hypoxic-ischemic encephalopathy. Because some studies included infants born at 35 weeks GA, hypothermia should be considered if they meet other criteria. Cooling for infants
Brigitte, Lemyre, Vann, Chau
openaire +2 more sources
In neonates with hypoxic–ischemic encephalopathy (HIE), adverse neurodevelopmental outcomes (NDO) remain common. Amplitude‐integrated EEG demonstrates strong prognostic value for early prediction, while cranial ultrasound (cUS) provides complementary but less definitive information.
Meirong Shu +6 more
wiley +1 more source
Mast Cell-Microglia Crosstalk Drives Aberrant Synaptic Pruning Through PAR-2/MAPK/NF-κB Signaling in Neonatal Hypoxic-Ischemic Encephalopathy. [PDF]
Following neonatal hypoxic–ischemic injury, hippocampal mast cell degranulation releases tryptase, which activates microglial PAR‐2 receptors to trigger p38 MAPK/NF‐κB signaling and drive aberrant synaptic engulfment. This pathological mast cell–microglia crosstalk leads to progressive synaptic loss and long‐term cognitive impairment.
Yang Y +13 more
europepmc +2 more sources

